Merck & Co., Inc: all 2,453 studies
Page 14 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007)CompletedNCT00654420Phase 2Results posted
- A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)CompletedNCT00648648Phase 1Results posted
- Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)CompletedNCT00642993Phase 2Results posted
- Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)CompletedNCT00642954Phase 1Results posted
- Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)TerminatedNCT00638963Phase 2Results posted
- Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)TerminatedNCT00638157Phase 4Results posted
- An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)CompletedNCT00635830Phase 1Results posted
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)CompletedNCT00635804Phase 1Results posted
- A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)CompletedNCT00635778Phase 1Results posted
- A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)CompletedNCT00635648Phase 3Results posted
- A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)CompletedNCT00632931Phase 1Results posted
- Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)CompletedNCT00632502Phase 2Results posted
- Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)TerminatedNCT00632203Phase 2Results posted
- A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)CompletedNCT00631657Phase 3Results posted
- A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)CompletedNCT00631488Phase 2Results posted
- Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid ArthritisCompletedNCT00626275Phase 2Results posted
- Induced Sputum Study (0000-065)CompletedNCT00623714Phase 1Results posted
- Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)TerminatedNCT00620659Phase 2Results posted
- Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)CompletedNCT00620113Phase 2Results posted
- Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)CompletedNCT00619359Phase 3Results posted
- A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)CompletedNCT00618995Phase 1Results posted
- A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)TerminatedNCT00617890Phase 2Results posted
- Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)CompletedNCT00617123Phase 3Results posted
- Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)CompletedNCT00614393Phase 2Results posted
- Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)CompletedNCT00610675Phase 3Results posted
- Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)CompletedNCT00610649Phase 2Results posted
- Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)CompletedNCT00610441Phase 2Results posted
- Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)TerminatedNCT00604968Phase 4Results posted
- A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)CompletedNCT00604188Phase 4Results posted
- Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT00603265Phase 2Results posted
- Bunionectomy Study (0000-063)CompletedNCT00601458Phase 1Results posted
- Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)CompletedNCT00599755Phase 1Results posted
- A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Japanese Participants. Part A (P05957)CompletedNCT00591786Phase 2Results posted
- A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956)CompletedNCT00591409Phase 2Results posted
- Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract SurgeryCompletedNCT00575380Phase 4Results posted
- Study of AzaSite Versus Vigamox in the Tears of Healthy VolunteersCompletedNCT00575367Phase 4Results posted
- A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)CompletedNCT00572910Phase 2Results posted
- Neuropathic Pain Syndrome Patient Study (MK-0000-072)CompletedNCT00570310Phase 1Results posted
- Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)CompletedNCT00567112Phase 1Results posted
- Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)CompletedNCT00566527Phase 3Results posted
- Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057)CompletedNCT00565084Phase 1Results posted
- Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy VolunteersCompletedNCT00564447Phase 4Results posted
- Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)CompletedNCT00561821Phase 3Results posted
- A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)CompletedNCT00561574Phase 3Results posted
- Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)CompletedNCT00561080Phase 3Results posted
- Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)CompletedNCT00560950Phase 3Results posted
- Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)CompletedNCT00560833Phase 3Results posted
- Safety Study of ProQuad® rHA in Infants (V221-037)CompletedNCT00560755Phase 3Results posted
- Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)CompletedNCT00559468Phase 3Results posted
- A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974)CompletedNCT00552929Phase 2Results posted
- A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)CompletedNCT00552617Phase 2Results posted
- A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)CompletedNCT00551213Phase 2Results posted
- Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)CompletedNCT00550771Phase 2Results posted
- ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)CompletedNCT00550745Phase 4Results posted
- A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)CompletedNCT00550732Phase 2Results posted
- ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)CompletedNCT00546819Phase 2Results posted
- Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)CompletedNCT00545584Phase 3Results posted
- Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)CompletedNCT00545064Phase 4Results posted
- Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)CompletedNCT00543543Phase 3Results posted
- Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)CompletedNCT00543387Phase 1Results posted
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)CompletedNCT00541775Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)CompletedNCT00541450Phase 3Results posted
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)CompletedNCT00541229Phase 1Results posted
- Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)TerminatedNCT00537316Phase 3Results posted
- Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)CompletedNCT00537017Phase 2Results posted
- Effect of MK0524A on Cholesterol Levels (0524A-048)CompletedNCT00536510Phase 3Results posted
- PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)CompletedNCT00536263Phase 3Results posted
- Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)CompletedNCT00535743Phase 2Results posted
- ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)CompletedNCT00535730Phase 3Results posted
- Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)CompletedNCT00535496Phase 3Results posted
- Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)CompletedNCT00535288Phase 3Results posted
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)CompletedNCT00535236Phase 1Results posted
- Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic ConjunctivitisCompletedNCT00534794Phase 4Results posted
- Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)CompletedNCT00534248Phase 3Results posted
- MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)CompletedNCT00532935Phase 3Results posted
- A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)CompletedNCT00529659Phase 2Results posted
- A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)TerminatedNCT00529373Phase 3Results posted
- Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)TerminatedNCT00527943Phase 3Results posted
- Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)CompletedNCT00526474Phase 3Results posted
- Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)TerminatedNCT00521924Phase 3Results posted
- Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)TerminatedNCT00518687Phase 2/3Results posted
- Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)CompletedNCT00518622Phase 1Results posted
- A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)CompletedNCT00511667Phase 1Results posted
- An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)CompletedNCT00511472Phase 1Results posted
- Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)CompletedNCT00511108Phase 1Results posted
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)CompletedNCT00509262Phase 3Results posted
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)CompletedNCT00509236Phase 3Results posted
- A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)CompletedNCT00506389Phase 3Results posted
- MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)CompletedNCT00506077Phase 2Results posted
- An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)CompletedNCT00496626Phase 3Results posted
- Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)CompletedNCT00496054Phase 3Results posted
- Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)TerminatedNCT00493805Phase 4Results posted
- A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)CompletedNCT00491764Phase 2Results posted
- Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)TerminatedNCT00491374Phase 4Results posted
- Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)TerminatedNCT00486720Phase 2Results posted
- Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)CompletedNCT00485758Phase 3Results posted
- Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)CompletedNCT00483704Phase 3Results posted
- MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)CompletedNCT00482729Phase 3Results posted
- Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)CompletedNCT00482612Phase 3Results posted
- MK-0524B Lipid Study (MK-0524B-063)CompletedNCT00479882Phase 3Results posted